Miguel Quintela-Fandino

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer.

Luis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra

|Sep 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora

|Mar 17, 2021
Mitochondrial Inhibition: a Treatment Strategy in Cancer?

Maria J Bueno, Jose L Ruiz-Sepulveda, Miguel Quintela-Fandino

Pageof 1